CONSTITUENT REPORT
alpha-Terpineol
alpha-Terpineol is a monoterpene alcohol found across eucalyptus, citrus-distilled, laurel, petitgrain, and many other aromatic oils. The strongest public evidence base covers identity, fragrance use, and preclinical anti-inflammatory research, with additional animal work on pain and oxidative-stress-related models. Human therapeutic evidence remains limited, so AromaForge should frame alpha-terpineol as a well-documented aroma constituent with promising but still mostly nonclinical bioactivity data.
Chemical identity and composition
PubChem and NIST identify alpha-terpineol as C10H18O with the core p-menth-1-en-8-ol structure. In fragrance and essential-oil literature, alpha-terpineol may appear as a single isomer or within broader terpineol mixtures, so this record is restricted to the alpha-terpineol constituent rather than the mixed-isomer terpineol material.
Aroma and practical use
- Use the recorded floral, lilac-like, citrus-woody, piney descriptors to explore a blend's scent character; perceived strength also depends on the other ingredients.
- Compare the recorded goal signals with the intended purpose, while keeping model assumptions separate from observed study outcomes.
- Review the flagged use concerns across every contributing oil and the selected dilution.
- Read the route, preparation and experimental context before using a study finding to choose an oil.
Reported benefits and effects
Findings retain their study context. An animal or laboratory result describes that experiment.
anti inflammatory related research
A Journal of Agricultural and Food Chemistry study reported that alpha-terpineol inhibited IL-6 formation in orange-juice-exposed buccal cells and also inhibited IL-6 receptor gene-expression readouts.
Measured: IL-6 formation and IL-6 receptor gene expression
This experimental finding does not establish benefit, dose or safety in people using this blend.
mechanical hypernociception and inflammation
A Basic & Clinical Pharmacology & Toxicology study reported that alpha-terpineol inhibited carrageenan- and TNF-alpha-related mechanical hypernociception, reduced neutrophil influx in pleurisy, and lowered nitrite production in murine macrophages.
Measured: hypernociception, neutrophil influx, and nitrite production
This experimental finding does not establish benefit, dose or safety in people using this blend.
oxidative stress and memory model
A rat ischemia study reported improved spatial-memory and synaptic-plasticity measures with alpha-terpineol, alongside reduced hippocampal lipid peroxidation in the tested model.
Measured: spatial memory, long-term potentiation, and hippocampal lipid peroxidation
This experimental finding does not establish benefit, dose or safety in people using this blend.
How it contributes to goal calculations
Model markers guide the formulation score. They are separate from the source findings above.
Use concerns and concentration limits
Sensitization concernFlagged
Flagged in the constituent reference; assess the source, route and finished-product concentration.
Phototoxicity concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Oxidation concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Penetration enhancementNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
A recorded constituent reference, not a recommended oil dilution. Product category, source applicability and all contributing oils must be checked before use.
unverified reference · No source provenance attachedA 2024 RIFM safety assessment for terpineol reported no genotoxicity concern, no skin-sensitization concern under current declared fragrance-use levels, no expected photoirritation or photoallergenicity, and calculated margins of exposure above 100 for repeated-dose, reproductive-toxicity, and local-respiratory endpoints.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No direct public citation is attached to this entry.
The cited RIFM document evaluates the terpineol material class rather than only isolated alpha-terpineol, so safety interpretation here is strongest for fragrance-risk context and weaker for therapeutic-style exposure claims.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No direct public citation is attached to this entry.
Preclinical bioactivity papers do not replace constituent-specific human dosing, dermal-limit, or clinical-tolerability studies.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No direct public citation is attached to this entry.
Constituents it may interact with
These are research candidates recorded in the interaction matrix. They do not add a proven-amplification bonus to the score.
Terpinen-4-olOpposing candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read Terpinen-4-ol report →LimoneneAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
human clinical · effect
No source citation attached.
Read Limonene report →LinaloolAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
human clinical · effect
No source citation attached.
Read Linalool report →alpha-PineneAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read alpha-Pinene report →1,8-cineoleOpposing candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
animal · effect
No source citation attached.
Read 1,8-cineole report →Linalyl acetateAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read Linalyl acetate report →FarnesolAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read Farnesol report →Terpinen-4-olAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · whole_oil
No source citation attached.
Read Terpinen-4-ol report →GeraniolAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read Geraniol report →1,8-cineoleAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · whole_oil
No source citation attached.
Read 1,8-cineole report →citralAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read citral report →p-CymeneNeutral record
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read p-Cymene report →Terpinen-4-olAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read Terpinen-4-ol report →CarvacrolAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read Carvacrol report →How the effects were investigated
reduced il6 signaling
In oral buccal cells, alpha-terpineol reduced IL-6 formation and also inhibited IL-6 receptor gene-expression readouts in the cited in vitro model.
This experimental finding does not establish benefit, dose or safety in people using this blend.
suppressed inflammatory mediator output
A mouse and macrophage study reported reduced carrageenan-linked hypernociception, neutrophil influx, and LPS-induced nitrite production after alpha-terpineol exposure.
This experimental finding does not establish benefit, dose or safety in people using this blend.
What this report cannot establish
- A reported constituent percentage does not establish an effective human therapeutic dose or the amount absorbed into the body.
- The presence of a constituent does not guarantee a clinical benefit, rash treatment or sleep improvement from a custom blend.
- An unflagged concern or missing use limit does not establish safety for ingestion, inhalation, skin exposure or a particular person.
- A candidate constituent interaction does not establish that two oils amplify one another at the selected proportions.
- Constituent descriptors alone do not establish a precise top, heart or base lifetime in a finished blend.
Known data gaps (6)
- No human clinical trials specific to isolated alpha-terpineol were verified in this research pass.
- Several activity papers use injection or experimental-dose paradigms that do not map cleanly to normal fragrance or aromatics use.
- The strongest public safety review is for terpineol as a fragrance material class rather than alpha-terpineol alone.
- The numeric dermal reference lacks source provenance; a verified flag alone is insufficient.
- Some findings do not record an explicit exposure route; consult the linked study before applying them to a use.
- Interaction candidates lack an attached source citation and remain unqualified.